Diagnostics

Future avenues of precision medicine in Parkinson’s: predicting impulse control disorders 6:48
Future avenues of precision medicine in Parkinson’s: predicting impulse control disorders
Alice Chen-Plotkin • 20 Sep 2021
RBD and Parkinson’s disease: news from MDS 2021 2:14
RBD and Parkinson’s disease: news from MDS 2021
Claudio Bassetti • 23 Sep 2021
Diagnosing RBD in the context of neurodegeneration 2:46
Diagnosing RBD in the context of neurodegeneration
Claudio Bassetti • 23 Sep 2021
Precision medicine in GBA-associated PD – where are we heading? 3:06
Precision medicine in GBA-associated PD – where are we heading?
Alice Chen-Plotkin • 20 Sep 2021
Amyloid-β in Alzheimer’s disease: pathogenic or protective? 5:29
Amyloid-β in Alzheimer’s disease: pathogenic or protective?
George Perry • 28 Sep 2021
Assessing language deficits in bvFDT in Latin America 6:27
Assessing language deficits in bvFDT in Latin America
Adolfo Garcia • 20 Sep 2021
Recognizing atypical Alzheimer’s disease 5:22
Recognizing atypical Alzheimer’s disease
João Massano • 29 Sep 2021
Imaging approaches for acute ischemic stroke 4:19
Imaging approaches for acute ischemic stroke
Marc Fisher • 28 Sep 2021
sGFAP: a potential diagnostic and prognostic marker in FTD 2:20
sGFAP: a potential diagnostic and prognostic marker in FTD
Annakaisa Haapasalo • 16 Sep 2021
The need for improved prognostic markers in Alzheimer’s disease 1:02
The need for improved prognostic markers in Alzheimer’s disease
Alberto Lleó • 1 Sep 2021
Differential diagnosis from limb-girdle muscular dystrophies 2:11
Differential diagnosis from limb-girdle muscular dystrophies
Marianne de Visser • 28 Sep 2021
VAMP-2 as a CSF marker of cognitive decline in Alzheimer’s disease 2:19
VAMP-2 as a CSF marker of cognitive decline in Alzheimer’s disease
Alberto Lleó • 1 Sep 2021
Differential early subcortical involvement in genetic FTD 2:48
Differential early subcortical involvement in genetic FTD
Martina Bocchetta • 24 Sep 2021
Genetics in Alzheimer’s disease: what have we learned so far? 5:30
Genetics in Alzheimer’s disease: what have we learned so far?
George Perry • 28 Sep 2021
The future of stroke imaging: better availability of the current tools 5:16
The future of stroke imaging: better availability of the current tools
Marc Fisher • 28 Sep 2021
The diagnostic and therapeutic landscape of MS in 2021 2:08
The diagnostic and therapeutic landscape of MS in 2021
Xavier Montalban • 23 Sep 2021
The content of VJNeurology is intended for healthcare professionals